Immunovant Inc (IMVT.O)

+ 收藏

资产负债表(Immunovant Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年三季报2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报
截止日期 2025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 0331033103310331033103310331
原始币种 美元美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 会员可见会员可见会员可见会员可见374,685,000.00472,941,000.00560,005,000.00
 应收账款及票据(元) 会员可见会员可见会员可见会员可见2,224,000.001,876,000.002,417,000.00
 预付款项及其他应收款流动(元) 会员可见会员可见会员可见会员可见35,632,000.0032,555,000.0026,625,000.00
 可收回本期税项(元) ---会员可见---
 流动资产合计(元) 会员可见会员可见会员可见会员可见412,541,000.00507,372,000.00589,047,000.00
非流动资产:
 物业、厂房及设备(元) 会员可见会员可见会员可见会员可见752,000.00671,000.00565,000.00
 非流动资产其他项目(元) 会员可见会员可见会员可见会员可见7,639,000.007,664,000.0066,000.00
 非流动资产合计(元) 会员可见会员可见会员可见会员可见8,391,000.008,335,000.00631,000.00
总资产(元) 会员可见会员可见会员可见会员可见420,932,000.00515,707,000.00589,678,000.00
流动负债:
 融资租赁负债流动(元) ---会员可见23,000.0047,000.0069,000.00
 应付账款及票据(元) 会员可见会员可见会员可见会员可见19,816,000.0020,727,000.0011,035,000.00
 其他应付款及应计费用(元) 会员可见会员可见会员可见会员可见48,476,000.0045,879,000.0033,914,000.00
 流动负债其他项目(元) ---会员可见---
 流动负债合计(元) 会员可见会员可见会员可见会员可见68,315,000.0066,653,000.0045,018,000.00
非流动负债:
总负债(元) 会员可见会员可见会员可见会员可见68,315,000.0066,653,000.0045,018,000.00
股东权益:
 普通股(元) 会员可见会员可见会员可见会员可见14,000.0014,000.0014,000.00
 股本溢价(元) 会员可见会员可见会员可见会员可见1,483,198,000.001,469,082,000.001,455,659,000.00
 留存收益(元) 会员可见会员可见会员可见会员可见-1,133,074,000.00-1,021,952,000.00-912,833,000.00
 累计其他全面收益(元) 会员可见会员可见会员可见会员可见2,479,000.001,910,000.001,820,000.00
 归属于母公司股东权益(元) 会员可见会员可见会员可见会员可见352,617,000.00449,054,000.00544,660,000.00
 股东权益合计(元) 会员可见会员可见会员可见会员可见352,617,000.00449,054,000.00544,660,000.00
负债及股东权益合计(元) 会员可见会员可见会员可见会员可见420,932,000.00515,707,000.00589,678,000.00
公告日期 2026-02-062025-11-102025-08-112025-05-292025-02-062024-11-072024-08-06
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院